Values First Advisors, Inc. Seagen Inc. Transaction History

Values First Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$191.51 - $216.16 $50,750 - $57,282	-265 Reduced 11.61%	2,017 $427,000
Q2 2023 Aug 02, 2023	SELL	$187.64 - $206.25 $254,064 - $279,262	-1,354 Reduced 37.24%	2,282 $439,000
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $463,917 - $738,398	3,636 New	3,636 $736,000
Q2 2021 Nov 15, 2022	SELL	$135.08 - $161.1 $486,828 - $580,604	-3,604 Closed	0 $0
Q1 2021 Nov 15, 2022	BUY	$137.51 - $190.8 $495,586 - $687,643	3,604 New	3,604 $500,000

Q4 2020 Nov 15, 2022	BUY	$164.63 - $211.93 $457,506 - $588,953	2,779 New	2,779 $487,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Values First Advisors, Inc. with notifications on news.